Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation.
Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation.
复制标题
DOI:
10.1126/scitranslmed.3009124
复制
发表时间:
2014-10-01
影响因子:
17.1
通讯作者:
Bartlett NW
中科院分区:
文献类型:
--
作者:
Beale J;Jayaraman A;Jackson DJ;Macintyre JDR;Edwards MR;Walton RP;Zhu J;Man Ching Y;Shamji B;Edwards M;Westwick J;Cousins DJ;Yi Hwang Y;McKenzie A;Johnston SL;Bartlett NW
Rhinoviruses are the most common cause of virally-induced asthma exacerbations which continue to account for the greatest burden in terms of morbidity, mortality and cost associated with this disease. IL-25 activates type-2-driven inflammation and is potentially important in virally-induced asthma exacerbations. Rhinovirus-infected cultured asthmatic bronchial epithelial cells exhibited a heightened intrinsic capacity for IL-25 expression which correlated with donor atopic status. In vivo human IL-25 expression was greater in asthmatics at baseline and during experimental rhinovirus infection. In mice rhinovirus infection induced IL-25 expression and augmented allergen-induced IL-25. Blockade of the IL-25 receptor reduced many RV-induced exacerbation-specific responses including type-2 cytokine expression, mucus production and recruitment of eosinophils, neutrophils, basophils, T and non-T type-2 cells. We have identified that asthmatic epithelial cells possess increased intrinsic capacity for expression of a pro-type-2 cytokine in response to a viral infection and identify IL-25 as a key mediator in RV-induced exacerbations of pulmonary inflammation.